SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares.

Click here for additional information: https://kaskelalaw.com/case/select-medical/

On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a price of $16.50 per share in cash. Following the closing of the proposed transaction the company’s shares will no longer be publicly traded.

The investigation seeks to determine whether investors will be receiving sufficient financial consideration for their Select Medical shares, and whether the company’s representatives breached their fiduciary duties in agreeing to the $16.50 per share buyout price. Notably, at the time the proposed transaction was announced, at least one stock analyst was maintaining a price target for Select Medical’s shares of $19.00 per share.

The investigation seeks to determine whether investors will be receiving sufficient financial consideration for their Select Medical shares, and whether the company’s representatives breached their fiduciary duties in agreeing to the $16.50 per share buyout price.

Select Medical investors who would like to learn more about the investigation and their legal rights and options are encouraged to contact lead investigative attorney Adrienne Bell, Esq. at [phone] or by email at [e-mail]. You can also click on the following link or paste it into your browser to learn more:

https://kaskelalaw.com/case/select-medical/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation in contingent litigation. For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.

This communication may constitute attorney advertising in certain jurisdictions.